A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Participants With Advanced Solid Tumors
for Solid Tumors
18 locations incl. Birmingham
Sponsor: GlaxoSmithKline
Sex: All·Age: 18+
Code: NCT06431594·Phase 1·Recruiting